Safety and clinical effectiveness of intravitreal administration of bevacizumab (Lumiere(®)) in patients with neovascular age-related macular degeneration

The present study was an open-label, prospective, uncontrolled and multicenter clinical trial to investigate the safety and effectiveness of bevacizumab (Lumiere(®)) administered by the intravitreal route for the treatment of neovascular age-related macular degeneration (nAMD). A total of 22 patient...

Descripción completa

Detalles Bibliográficos
Autores principales: Benisek, Daniel A., Manzitti, Julio, Scorsetti, Daniel, Rousselot Ascarza, Andres M., Ascarza, Amalia A., Gomez Rancaño, Diego, Quercia, Romina, Ramirez Gismondi, Matias, Carpio Total, Mateo A., Scorsetti, María L., Spitzer, Eduardo, Lombas, Carola, Deprati, Matías, Penna, María Ines, Fernández, Francisco, Tinelli, Marcelo A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2020
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7571337/
https://www.ncbi.nlm.nih.gov/pubmed/33093900
http://dx.doi.org/10.3892/etm.2020.9291

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7571337/
https://www.ncbi.nlm.nih.gov/pubmed/33093900
http://dx.doi.org/10.3892/etm.2020.9291

Ejemplares similares